Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Theraworx is a brand of topical therapeutic products developed by Avadim Health, utilizing a proprietary Bionome Engineered Platform designed to optimize the skin's natural barrier and microbiome. The product line includes Theraworx Relief, an over-the-counter (OTC) topical foam or spray used for the prevention and treatment of muscle cramps, spasms, and restless legs, often formulated with homeopathic magnesium sulfate (Magnesia sulphurica). Another key product, Theraworx Protect, is a skin hygiene and infection prevention solution used in clinical settings to reduce the risk of healthcare-associated infections, such as urinary tract infections (UTIs), by maintaining a low skin pH and supporting antimicrobial activity without disrupting the skin's natural flora. Following Avadim Health's bankruptcy in 2021, the brand and its assets were acquired by Hayfin Capital Management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Theraworx.